Litcius/Paper detail

A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States

Megan Wallace, Hannah G. Rosenblum, Danielle Moulia, Karen R. Broder, Tom T. Shimabukuro, Christopher A. Taylor, Fiona P. Havers, Sarah Meyer, Kathleen Dooling, Sara E. Oliver, Stephen C. Hadler, Julia W. Gargano

2023Vaccine21 citationsDOIOpen Access PDF

Topics & Concepts

MedicineVaccinationImmunizationPandemicRisk assessmentCoronavirus disease 2019 (COVID-19)Advisory committeeEnvironmental healthFamily medicineImmunologyInfectious disease (medical specialty)Political scienceDiseasePublic administrationComputer securityAntigenComputer sciencePathologySARS-CoV-2 and COVID-19 ResearchHeparin-Induced Thrombocytopenia and ThrombosisViral Infections and Immunology Research
A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States | Litcius